Can Global Policies Boost Biosimilar Adoption Work in the US?

On this special episode of Not So Different honoring Global Biosimilars Week, Craig Burton, executive director of the Biosimilars Council, explores how global policies—from incentives to health equity strategies—could boost biosimilar adoption in the US.

---

By Craig Burton | Original Article

On this episode of Not So Different, The Center for Biosimilars® celebrating Global Biosimilars Week—an annual advocacy campaign promoting the use of biosimilars worldwide orchestrated by the International Generics and Biosimilars Association.

Joining us for this special episode is Craig Burton, executive director of the Biosimilars Council and senior vice president of policy and strategic alliances at the Association for Accessible Medicines. Craig is a leading voice in the biosimilar space, and together, we’ll explore a fascinating and timely question: Can global policies to boost biosimilar adoption work in the US?

From government incentives and substitution policies to international trade agreements and health equity strategies, we’ll dive into lessons learned from around the world. How do Europe, Canada, Latin America, Australia, and others foster biosimilar growth—and what can the US learn from these approaches?

To listen to the podcast episode, click here.